Tax1 binding protein 1 (TAX1BP1) participates in cellular signaling pathways and immune response mechanisms while helping cells survive. Myocardial infarction usually results from insufficient coronary blood flow which causes both hypoxia and myocardial cell death. Cell apoptosis together with cardiac tissue remodeling and inflammatory response represent key mechanisms within this process. TAX1BP1's capacity to control these biological mechanisms dictates its effect on heart performance and wellness.
Related Product
Acute Myocardial Infarction (MI)
MI stands as one of the leading global causes of death and heart failure. The condition of myocardial ischemic necrosis or MI emerges from coronary artery blockage and generally includes inflammation together with oxidative stress and apoptosis as part of its development. Since MI causes cardiac dysfunction and heart failure researchers must examine its pathological mechanisms and protective factors. Recent research demonstrates that Tax1 binding protein 1 (TAX1BP1) functions as an essential autophagy adaptor protein which regulates inflammatory responses while preserving mitochondrial homeostasis.
TAX1BP1 Physiological Activity
TAX1BP1 functions as a primary autophagy adaptor protein that controls inflammatory responses while also playing a role in apoptosis regulation and antiviral immunity defense. TAX1BP1 protects cardiomyocytes and maintains cellular homeostasis through its interaction with other proteins alongside its regulation of its own ubiquitination status. TAX1BP1 functions as a multifunctional protein primarily associated with:
Inflammation inhibition: Inhibition of the NLRP3 inflammasome results in decreased production of proinflammatory cytokines IL-1β and IL-18.
Autophagy regulation: The breakdown of defective proteins and mitochondria protects cellular stability.
Ubiquitination modification: The E3 ubiquitin ligase RNF34 regulates protein stability through K27-linked polyubiquitination mediation.
Mitochondrial protection: The strategy for protecting mitochondria works to prevent excessive reactive oxygen species (ROS) production and maintain mitochondrial membrane potential.
TAX1BP1 Is Directly Associated With the Development of Acute Myocardial Infarction (MI)
The Expression of TAX1BP1 Becomes Reduced as a Result of Acute Myocardial Infarction
After myocardial infarction cardiac tissues express lower levels of TAX1BP1 and higher levels of pro-inflammatory factors including IL-1β and IL-18. Diminished TAX1BP1 gene expression is linked to the intensification of inflammatory responses after a heart attack. When overactive the NLRP3 inflammasome functions as an essential element that promotes myocardial damage through post-MI inflammation. Research shows that enhanced TAX1BP1 expression effectively blocks NLRP3 inflammasome activation thereby reducing inflammatory mediator discharge and providing cardiac protection.
Overexpressing TAX1BP1 Leads to the Suppression of NLRP3 Inflammasome Activation
Overactive NLRP3 inflammasome exacerbates heart damage yet TAX1BP1 overexpression stops NLRP3 activation thereby reducing the release of inflammatory mediators which helps to alleviate myocardial injury from MI. Higher levels of TAX1BP1 expression reduce the size of heart infarcts while protecting the heart from damage after an acute myocardial infarction. Research using animal models of MI showed that animals with TAX1BP1 expression developed smaller infarct sizes together with improved cardiac function parameters such as ejection fraction and cardiac output. TAX1BP1 demonstrates protective effects which prevent heart damage during myocardial infarction.
TAX1BP1 Overexpression Preserves Mitochondrial Function in Cardiomyocytes
Myocardial infarction (MI) triggers mitochondrial dysfunction in heart muscle cells through the loss of membrane potential and increased ROS production but TAX1BP1 overexpression preserves membrane potential and minimizes ROS production which maintains mitochondrial activity and reduces heart tissue damage. TAX1BP1 functions as a protective agent for cardiomyocytes while ensuring energy supply continuity through specific mechanisms.
- Reducing ROS levels
- Maintaining mitochondrial membrane potential (MMP)
- Reducing activation of mitochondrial apoptosis pathways
TAX1BP1 Inhibits NLRP3 Mitochondrial Localization by Inhibiting the Interaction Between NLRP3 and MAVS
The mitochondrial antiviral signaling protein MAVS leads to the localization of NLRP3 on mitochondria which triggers the inflammatory process. TAX1BP1 blocks the interaction between NLRP3 and MAVS which stops NLRP3 activation on mitochondria and reduces inflammation.
Through the Autophagy Pathway TAX1BP1 Facilitates the Breakdown of MAVS
Through the autophagy pathway TAX1BP1 functions as an adaptor protein to degrade MAVS which leads to the suppression of pro-inflammatory signals and inhibition of MI-triggered inflammatory responses.
TAX1BP1 Functions by Bringing Together RNF34 to Produce K27-Linked Polyubiquitination on MAVS
Research shows that TAX1BP1 connects with RNF34 to activate K27-linked polyubiquitination of MAVS. The modification directs MAVS towards the autophagic degradation pathway which diminishes MAVS-induced inflammatory signals and shields cardiomyocytes from damage.
Tax1bp1 Regulates Signaling Pathways and Protects Cardiac Cells
TAX1BP1 controls signaling pathways that dictate cell survival and death mechanisms and defends cardiac cell longevity. TAX1BP1 helps prevent cardiac complications after a heart attack by reducing excessive inflammation which leads to cardiac damage.
TAX1BP1 functions as a key player in heart disease development which positions it as an important therapeutic target to develop new treatments that lower myocardial infarction risks and enhance cardiac performance. Additional research will reveal the precise function of this mechanism and its potential clinical applications.
TAX1BP1 serves as a critical protective element against damage caused by myocardial infarction.
References
- Zhang, Q., et al. Centrosome protein TAX1BP mediates STING-dependent immune response and potentiates anti-PD-1 efficacy in Hepatocellular Carcinoma. Molecular Therapy. (2025).
- Xu, H., et al. TAX1BP1 protects against myocardial infarction-associated cardiac anomalies through inhibition of inflammasomes in a RNF34/MAVS/NLRP3-dependent manner. Science Bulletin. 2021, 66(16): 1669-1683.
.
